Basil Mathew

Engineering of a linear inactive analog of human β‐defensin 4 to generate peptides with potent antimicrobial activity

R. Nagaraj, Himanshu Sharma, Basil Mathew, 2015, Journal of peptide science : an official publication of the European Peptide Society.

Conflicts and Divergent Perspectives to Protect Traditional Knowledge and Indigenous People

Basil Mathew, 2013 .

Yersinia pestis lipopolysaccharide remodeling confers resistance to a Xenopsylla cheopis cecropin

M. Fisher, Basil Mathew, Kari L Aoyagi, 2021, bioRxiv.

Variations in the interaction of human defensins with Escherichia coli: Possible implications in bacterial killing

R. Nagaraj, Basil Mathew, 2017, PloS one.

Antimicrobial activity of human α-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs

R. Nagaraj, Basil Mathew, 2015, Peptides.

Antimicrobial activity of human α‐defensin 6 analogs: insights into the physico‐chemical reasons behind weak bactericidal activity of HD6 in vitro

R. Nagaraj, Basil Mathew, 2015, Journal of peptide science : an official publication of the European Peptide Society.

Traditional Knowledge Protection: A Critical study on Kani Tribal Community and their Benefit Sharing Model in Kerala

Basil Mathew, 2013 .

Antibacterial activity of Xenopsylla cheopis attacins against Yersinia pestis

M. Fisher, Basil Mathew, Kari L. Aoyagi, 2023, bioRxiv.

Chimeric analogs of human β-defensin 1 and θ-defensin disrupt pre-established bacterial biofilms.

Basil Mathew, Sudar Olli, R. Nagaraj, 2017, Bioorganic & medicinal chemistry letters.